Jesús Guinea-rekin lankidetzan egindako argitalpenak (8)

2023

  1. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

2022

  1. Different performance of three point-of-care SARS-CoV-2 antigen detection devices in symptomatic patients and close asymptomatic contacts: a real-life study

    Clinical Microbiology and Infection, Vol. 28, Núm. 6, pp. 865-870

  2. Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers

    Microbiology Spectrum, Vol. 10, Núm. 1

2021

  1. Inference of active viral replication in cases with sustained positive reverse transcription-PCR results for SARS-CoV-2

    Journal of Clinical Microbiology, Vol. 59, Núm. 2

  2. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity

    Mycoses, Vol. 64, Núm. 2, pp. 132-143

2019

  1. Assessment of the anti-biofilm effect of micafungin in an animal model of catheter-related candidemia

    Medical Mycology, Vol. 57, Núm. 4, pp. 496-503

2016

  1. Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels

    Medical Mycology, Vol. 54, Núm. 4, pp. 353-360

2015

  1. Antifungal stewardship in a tertiary-care institution: A bedside intervention

    Clinical Microbiology and Infection, Vol. 21, Núm. 5, pp. 492.e1-492.e9